Recurrent Urethral Cancer Completed Phase 2 Trials for Ixabepilone (DB04845)

Also known as: Urethral cancer recurrent / Urethra cancer recurrent

IndicationStatusPhase
DBCOND0028817 (Recurrent Urethral Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00021099Ixabepilone in Treating Patients With Advanced Urinary Tract CancerTreatment